Hike in pharma hiring on the cards
The buzz at recruitment firms and job portals is that hiring for new jobs, as well as replacements in 2014 will continue to be…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Time to get proactive
Caught in the midst of a talent crunch and an industry under strict regulatory lens, HR departments within companies need to rise…
Nurturing the industry
Industry associations bridge the gap between companies, policy makers and talent pools. A look at some of their initiatives to…
’Agility and flexibility are key company attributes to attract talent’
Dietmar Eidens, Executive Vice President, Head of Human Resources, Merck speaks to Viveka Roychowdhury on the HR challenges faced…
’The opportunities are going to be better, but for better qualified and experienced…
Prakash Shanware, President and Chief Executive Officer, PeopleFirst, in an interaction with Sachin Jagdale, speaks about how the…
’ACRO agenda is to minimise headwind, take advantage of tailwind’
D A Prasanna, Founder Chairman, Ecron Acunova has taken over as the Chairman of Association of Contract Research Organizations…
Buyouts to increase in consumer, pharma, tech sectors in 2014: KPMGs M&A Predictor
As Indian economy shows signs of bottoming out, analysts expect 2014 to be a much better year with increased M&A sentiment
Venus Remedies receives Indonesian GMP certification for its Baddi unit
The GMP approval will soon pave way for marketing authorisations from Indonesia; Venus expecting registrations for 10 oncology…
Mylan launches first trastuzumab biosimilar, Hertraz, in India
Its indicated for the treatment of HER2-positive metastatic breast cancer and is available in two strengths
Gilead names Mylan as exclusive branded medicines business partner for India
Under the agreement, Mylan will market and distribute in India certain Gilead medications